Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.

Pharmaceutical

Pliant Therapeutics

Pliant Therapeutics' headquarters in Redwood City, CA, United States

Bernard Coulie

Hardean E. Achneck

Diane Ireland

Delphine Imbert

Director, Vendor Outsourcing

Senior Director, Vendor Outsourcing

Minnie Kuo

Lily Cheung

Tim Machajewski

Hans Hull

Keith Cummings

Monica Sandberg

Christopher Keenan

Fernando Rock

Bill DeGrado

Bertus Eksteen

Hal Chapman

Rik Derynck

Bill Greenlee

Naftali Kaminski

Brian Metcalf

Paul Noble

Dean Sheppard

Gayle Crowell

John Curnutte

David Pyott

Hoyoung Huh

Darren Cline

Thomas McCourt

Suzanne Bruhn

David Phillips

Katharine Knobil

The Research and Development Team at Pliant Therapeutics is dedicated to advancing the company's drug development programs targeting fibrotic diseases. This team engages in the discovery, design, and optimization of novel therapies with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway. Members collaborate closely to conduct experimental research, develop clinical candidates, and transition promising compounds from preclinical studies to clinical trials.

Research and Development Team

The Clinical Development and Operations Team at Pliant Therapeutics is responsible for designing, managing, and executing clinical trials to advance the company’s drug development programs targeting fibrotic diseases. They oversee all aspects of clinical development, including protocol design, regulatory compliance, clinical supply chain management, and trial logistics, ensuring efficient and effective progression from early-stage trials through to late-stage development.

Clinical Development and Operations Team

The Leadership Team at Pliant Therapeutics is responsible for setting the strategic direction of the company, overseeing drug development initiatives, and ensuring alignment across all functional areas. Comprising key executives, including the CEO, CFO, and VPs of various departments, the team focuses on advancing innovative therapies targeting fibrotic diseases while managing investor relations, regulatory compliance, and operational efficiency. Their collaborative efforts drive the company's mission to enhance patient outcomes through effective and targeted treatments.

Leadership Team

The Corporate Board at Pliant Therapeutics provides strategic oversight and governance, ensuring alignment with the company's mission to advance drug development for fibrotic diseases. They make high-level decisions on corporate policies, financial planning, and regulatory compliance, while guiding long-term growth and sustainability.

Corporate Board

The Regulatory and Program Management team at Pliant Therapeutics oversees the coordination and strategic planning for drug development programs, ensuring regulatory compliance and efficient portfolio management. This team is responsible for guiding manufacturing processes, managing clinical supply chains, and developing regulatory strategies to advance treatments targeting fibrotic diseases.

Regulatory and Program Management

The Human Resources and Hiring team at Pliant Therapeutics focuses on talent acquisition, employee development, and fostering a positive company culture. They manage recruitment, ensure quality hiring practices, support employee engagement, and oversee operations to maintain a productive and motivated workforce.

Human Resources and Hiring

Pliant Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Clinical Development and Operations Team

Leadership Team

Corporate Board

Regulatory and Program Management

Human Resources and Hiring

Offices

Pliant Therapeutics

Org chart

Board & advisors

Teams

Research and Development Team

Clinical Development and Operations Team

Leadership Team

Corporate Board

Regulatory and Program Management

Human Resources and Hiring

Offices

Related companies